PT Enterprises Europe Ltd. has successfully facilitated 13+ years of rigorous clinical research in the following key therapeutic areas:
• Oncology > Solid Tumor >Breast, Ovarian, Prostate, Lung, Colon, GI Stromal, Skin
Oncology >Hematological >Acute Myelogenous Leukemia, Chronic Lympocytic Leukemia, Myelodysplastic Syndrome, Mantle Cell Lymphoma
• Pediatric Oncology > Microphthalmia Transcription Factor Associated Tumors
• Central Nervous System > Alzheimer’s Disease, Bulimia, Depression, Schizophrenia
• Cardiovascular > Acute Myocardial Infarction
• HIV/AIDS > Anti-Retro Virals
• Infectious Disease > Hepatitis C, Influenza
• Endocrinology > Type II Diabetes
• Auto-Immune Disease > Rheumatoid Arthritis
• Rare Genetic Disease > Urea Cycle Disorder, Hereditary Inclusion Body Myopathy Disorder, Hepatic Encephalopathy
Pediatric Rare Genetic Disease > Urea Cycle Disorder
• Oncology Related Anemia